HWS116
/ Humanwell Healthcare
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 29, 2026
HWS116 Monotherapy in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=56 | Recruiting | Sponsor: Wuhan Humanwell Innovative Drug Research and Development Center Limited Company | Not yet recruiting ➔ Recruiting
Enrollment open • First-in-human • Monotherapy • Cholangiocarcinoma • Esophageal Cancer • Gastric Cancer • Oncology • Solid Tumor
February 18, 2026
HWS116 Monotherapy in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=56 | Not yet recruiting | Sponsor: Wuhan Humanwell Innovative Drug Research and Development Center Limited Company
First-in-human • Monotherapy • New P1 trial • Cholangiocarcinoma • Esophageal Cancer • Gastric Cancer • Solid Tumor
1 to 2
Of
2
Go to page
1